MANAGEMENT OF MYELODYSPLASTIC SYNDROMES WITH ERYTHROPOIESIS STIMULATING AGENTS (ESAS): A REAL-LIFE EXPERIENCE

被引：0
|
作者：
Cerchione, C. [1 ]
Vitagliano, O. [1 ]
Pareto, A. E. [1 ]
Di Perna, M. [1 ]
Cerciello, G. [1 ]
Soriente, I. [2 ]
Alfinito, F. [1 ]
Pane, F. [1 ]
机构：
[1] Hematol Ematol & Trapianto Federico II, Naples, Italy
[2] Osped Umberto I, Hematol, Nocera Inferiore, SA, Italy
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB2114
引用
收藏
页码：840 / 840
页数：1
相关论文
共 50 条
  • [1] MANAGEMENT OF MYELODYSPLASTIC SYNDROMES WITH ERYTHROPOIESIS STIMULATING AGENTS (ESAS) IN REAL-LIFE EXPERIENCE: AN UPDATE FROM RECAMDS
    Cerchione, C.
    Vitagliano, O.
    Della Pepa, R.
    Cerciello, G.
    Pareto, A. E.
    Di Perna, M.
    Soriente, I.
    D'Arco, A. M.
    Danise, P.
    Alfinito, F.
    Pane, F.
    LEUKEMIA RESEARCH, 2017, 55 : S57 - S58
  • [2] MANAGEMENT OF MYELODYSPLASTIC SYNDROMES WITH ERYTHROPOIESIS STIMULATING AGENTS IN REAL-LIFE EXPERIENCE: AN UPDATE FROM RECAMDS
    Cerchione, C.
    Vitagliano, O.
    Della Pepa, R.
    Cerciello, G.
    Pareto, A. E.
    Di Perna, M.
    Soriente, I.
    Danise, P.
    D'Arco, A. M.
    Alfinito, F.
    Pane, F.
    HAEMATOLOGICA, 2017, 102 : 767 - 768
  • [3] MANAGEMENT OF LOW-RISK MYELODYSPLASTIC SYNDROMES WITH ERYTHROPOIESIS STIMULATING AGENTS (ESAS) IN REAL-LIFE EXPERIENCE: AN UPDATE FROM RECAMDS (REGISTRO CAMPANO DELLE SINDROMI MIELODISPLASTICHE)
    Cerchione, C.
    Vitagliano, O.
    Della Pepa, R.
    Cerciello, G.
    Pareto, A. E.
    Di Perna, M.
    Soriente, I.
    D'Arco, A. M.
    Danise, P.
    Califano, C.
    Alfinito, F.
    Pane, F.
    HAEMATOLOGICA, 2017, 102 : 59 - 59
  • [4] MYELODYSPLASTIC SYNDROMES AND ERYTHROPOIESIS STIMULATING AGENTS (ESAS) : EVALUATION OF ERYTHROPOIETIC ASPECTS AND ANALYSIS OF RESPONSE
    Cerchione, C.
    Vitagliano, O.
    Cerciello, G.
    Pareto, A. E.
    Di Perna, M.
    Soriente, I.
    D'Arco, A. M.
    Danise, P.
    Alfinito, F.
    Pane, F.
    HAEMATOLOGICA, 2016, 101 : S115 - S115
  • [5] Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a “Gruppo Romano Mielodisplasie (GROM)” multicenter study
    Francesco Buccisano
    Anna Lina Piccioni
    Carolina Nobile
    Marianna Criscuolo
    Pasquale Niscola
    Caterina Tatarelli
    Luana Fianchi
    Nicoletta Villivà
    Benedetta Neri
    Ida Carmosino
    Svitlana Gumenyuk
    Stefano Mancini
    Maria Teresa Voso
    Luca Maurillo
    Massimo Breccia
    Gina Zini
    Adriano Venditti
    Susanna Fenu
    Maria Antonietta Aloe Spiriti
    Roberto Latagliata
    Annals of Hematology, 2016, 95 : 1059 - 1065
  • [6] Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study
    Buccisano, Francesco
    Piccioni, Anna Lina
    Nobile, Carolina
    Criscuolo, Marianna
    Niscola, Pasquale
    Tatarelli, Caterina
    Fianchi, Luana
    Villiva, Nicoletta
    Neri, Benedetta
    Carmosino, Ida
    Gumenyuk, Svitlana
    Mancini, Stefano
    Voso, Maria Teresa
    Maurillo, Luca
    Breccia, Massimo
    Zini, Gina
    Venditti, Adriano
    Fenu, Susanna
    Spiriti, Maria Antonietta Aloe
    Latagliata, Roberto
    ANNALS OF HEMATOLOGY, 2016, 95 (07) : 1059 - 1065
  • [7] SUPPORTIVE CARE IN LOW-RISK MYELODYSPLASTIC SYNDROMES: ROLE OF ERYTHROPOIESIS STIMULATING AGENTS (ESAS)
    Cerchione, C.
    Alfinito, F.
    Soriente, I.
    D'Arco, A. M.
    Danise, P.
    Cerciello, G.
    Musuraca, G.
    Lucchesi, A.
    Di Battista, V.
    Cangini, D.
    Giannini, M. B.
    Ronconi, S.
    Ceccolini, M.
    Pane, F.
    Martinelli, G.
    HAEMATOLOGICA, 2022, 107 : 65 - 66
  • [8] ROLE OF ERYTHROPOIESIS STIMULATING AGENTS (ESAS) IN SUPPORTIVE CARE OF LOW-RISK MYELODYSPLASTIC SYNDROMES
    Cerchione, C.
    Martinelli, G.
    Soriente, I.
    D'Arco, A. M.
    Danise, P.
    Cerciello, G.
    Di Battista, V.
    Cangini, D.
    Giannini, M. B.
    Pane, F.
    Alfinito, F.
    HAEMATOLOGICA, 2019, 104 : 147 - 148
  • [9] Supportive Care in Low-Risk Myelodysplastic Syndromes: Role of Erythropoiesis Stimulating Agents (ESAs)
    Cerchione, Claudio
    Alfinito, Fiorella
    Giannini, Benedetta Maria
    Pane, Fabrizio
    Musuraca, Gerardo
    Martinelli, Giovanni
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S318 - S318
  • [10] ROLE OF ERYTHROPOIESIS STIMULATING AGENTS (ESAS) IN SUPPORTIVE CARE OF LOW-RISK MYELODYSPLASTIC SYNDROMES
    Cerchione, C.
    Alfinito, F.
    Soriente, I.
    D'Arco, A. M.
    Danise, P.
    Cerciello, G.
    Musuraca, G.
    Lucchesi, A.
    Di Battista, V.
    Cangini, D.
    Giannini, M. B.
    Ronconi, S.
    Ceccolini, M.
    Pane, F.
    Martinelli, G.
    HAEMATOLOGICA, 2020, 105 : S76 - S76
12345